EMN vs EOLS · P/E 21, rev $9.38B vs rev $266.3M
Eastman Chemical Company (EMN) versus Evolus Inc (EOLS) — a side-by-side from cached financials, not a winner call.
Eastman Chemical Company (EMN) is a specialty chemicals company listed on US.
Evolus Inc (EOLS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported EMN revenue for 2024-12-31 was $9.38B. Net income was $908.0M. Revenue was up 1.9% from 2023-12-31 to 2024-12-31. EMN currently screens at market cap $8.21B and trailing P/E 20.8.
Latest reported EOLS revenue for 2024-12-31 was $266.3M. Net income was -$50.4M. Revenue was up 31.8% from 2023-12-31 to 2024-12-31. EOLS currently screens at market cap $597.0M.
EMN currently screens at market cap $8.21B and trailing P/E 20.8. EOLS currently screens at market cap $597.0M.
Not investment advice. Open the EMN and EOLS stock pages for the full models.
Not investment advice.